Skip to content

Patient diagnosis in Covid-19 vaccine trial still pending: AstraZeneca

September 9, 2020

To review, AstraZeneca yesterday suspended its Phase 3 trial of Covid-19 vaccine candidate AZD1222 after one U.K. participant suffered a serious adverse reaction.

It was reported today that the reaction was a rare inflammatory condition affecting the spinal cord called transverse myelitis, that is caused by infections or immune system disorders.

The company a short time ago said those reports are incorrect, and that there’s been no final diagnosis of yet. The company also confirms that there was a short pause in the trial in July after one volunteer was confirmed to have an undiagnosed case of multiple sclerosis, unrelated to the vaccine.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: